These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statins for the prevention of venous thromboembolism? a narrative review. Sehdev A; Wanner N; Pendleton RC Hosp Pract (1995); 2012 Aug; 40(3):13-8. PubMed ID: 23086090 [TBL] [Abstract][Full Text] [Related]
4. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients. Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448 [TBL] [Abstract][Full Text] [Related]
5. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer. Walenga JM; Lyman GH Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978 [TBL] [Abstract][Full Text] [Related]
6. [Thoughts about thromboembolic events prophylaxis in cancer patients]. Pikó B; Kremer IM; Rahoty P; Bassam A; Dimák S; Kis A; Csiffári M; Rus-Gal P; Szabó Z; Veréb B; Zsilak J Magy Onkol; 2011 Sep; 55(3):164-9. PubMed ID: 21918741 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Zwicker JI Thromb Res; 2010 Apr; 125 Suppl 2():S89-91. PubMed ID: 20434015 [TBL] [Abstract][Full Text] [Related]
9. [Cancer and venous thromboembolism]. Meyer G; Belmont L Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900 [TBL] [Abstract][Full Text] [Related]
10. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer. Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102 [TBL] [Abstract][Full Text] [Related]
11. Prevention of deep vein thrombosis in cancer patients. Lee AY Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798 [TBL] [Abstract][Full Text] [Related]
12. [Secondary prevention of venous thromboembolism in patients with cancer]. Meyer G Rev Prat; 2011 Nov; 61(9):1249-51. PubMed ID: 22308809 [TBL] [Abstract][Full Text] [Related]
13. Thromboprophylaxis in cancer patients. Carrier M; Lee AY Semin Thromb Hemost; 2014 Apr; 40(3):395-400. PubMed ID: 24599436 [TBL] [Abstract][Full Text] [Related]
14. [Prevention and treatment of venous thromboembolism in patients with cancer]. Struve S; Wendtner CM Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155 [No Abstract] [Full Text] [Related]
15. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
16. Thromboprophylaxis in patients with multiple organ injuries--is there an alternative to low-molecular-weight heparins (LMWH)? Krasiński Z; Urbanek T; Krasińska B; Kaczmarczyk J Ortop Traumatol Rehabil; 2011; 13(3):229-40. PubMed ID: 21750353 [TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis during chemotherapy in patients with advanced cancer. Agnelli G; Verso M Thromb Res; 2010 Apr; 125 Suppl 2():S17-20. PubMed ID: 20433999 [TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care? Burris HA Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456 [TBL] [Abstract][Full Text] [Related]
19. Management of venous thromboembolism in patients with cancer. Noble S; Jenkins DA Br J Hosp Med (Lond); 2009 Jul; 70(7):380-5. PubMed ID: 19584778 [TBL] [Abstract][Full Text] [Related]
20. Are all low molecular weight heparins equivalent in the management of venous thromboembolism? Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]